0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,123USDGBP
EUR$4,850USDGBP
From
EUR$4,123USDGBP
EUR$4,850USDGBP
From
EUR$4,123USDGBP
EUR$4,850USDGBP
From
EUR$4,123USDGBP
EUR$4,850USDGBP
From
EUR$4,123USDGBP
EUR$4,850USDGBP
Neuroscience Antibodies & Assays Market Report 2025 - Product Thumbnail Image

Neuroscience Antibodies & Assays Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,549USDGBP
EUR$2,999USDGBP
Asia-Pacific Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 96 Pages
  • Asia Pacific
From
EUR$3,950USDGBP
Middle East and Africa Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 81 Pages
  • Africa, Middle East
From
EUR$3,450USDGBP
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more